New data highlights efficacy and safety of MCI treatment

25 Oct 2024
New data highlights efficacy and safety
of MCI treatment
Two experts discussed the finer points on identifying symptoms of mild cognitive impairment (MCI) and effective treatment options for patients with MCI at the recent 18th International Congress of the Asian Society Against Dementia (ASAD) in Penang.
Sponsored as an educational program by Schwabe Pharma.

Related MIMS Drugs

Resources

MY-SPA-004

MY-SPA-004

MY-SPA-004

MY-SPA-004